HYGIEIA GROUP(01650.HK)公開發售超購約18.92倍 預計7月3日上市
格隆匯 7 月 2日丨HYGIEIA GROUP(01650.HK)發佈公告,公司擬發售股份5億股,其中公開發售股份1億股,配售股份4億股,另有15%超額配股權;最終發售價已釐定為每股發售股份0.25港元,每手買賣單位8000股;預期股份將於2020年7月3日於聯交所主板掛牌上市。
公開發售股份獲大幅超額認購,已合共接獲23,855份有效申請,以認購合共約9.96億股公開發售股份,相當於公開發售項下初步可供認購公開發售股份總數的約19.92倍。配售股份已獲輕微認購不足,合共認購約4.35億股配售股份,佔配售項下初步提呈發售股份總數的約0.97倍。
按發售價為每股發售股份0.25港元及5億股發售股份計算,公司將收取的股份發售所得款項淨額估計約為6920萬港元。其中,估計所得款項淨額的33.0%將用於擴大公司的服務能力及提高公司服務的質量及效率;估計所得款項淨額的57.0%將用於擴大公司於新加坡的服務範圍;估計所得款項淨額的10.0%將留作普通營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.